Shanmugam Muthian, Ph.D.
|Medical College of Wisconsin, Milwaukee, WI, United States|
Mean distance: 16.98 (cluster 19)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Mnich SJ, Hiebsch RR, Huff RM, et al. (2010) Anti-inflammatory properties of CB1-receptor antagonist involves beta2 adrenoceptors. The Journal of Pharmacology and Experimental Therapeutics. 333: 445-53|
|Cortes-Burgos LA, Zweifel BS, Settle SL, et al. (2009) CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain. European Journal of Pharmacology. 617: 59-67|
|Muthian S, Rademacher DJ, Roelke CT, et al. (2004) Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience. 129: 743-50|
|Patel S, Gerrits R, Muthian S, et al. (2002) The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat. Neuroscience Letters. 335: 95-8|
|Muthian S, Nithipatikom K, Campbell WB, et al. (2000) Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier. The Journal of Pharmacology and Experimental Therapeutics. 293: 289-95|
|Hillard CJ, Muthian S, Kearn CS. (1999) Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. Febs Letters. 459: 277-81|
|Tsou K, Nogueron MI, Muthian S, et al. (1998) Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neuroscience Letters. 254: 137-40|
|Edgemond WS, Greenberg MJ, McGinley PJ, et al. (1998) Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase. The Journal of Pharmacology and Experimental Therapeutics. 286: 184-90|